A Multi-center RCT Trial on Prognosis of Patients With Anticoagulation and DAPT Therapy After LAAC
Status:
Unknown status
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the different dosage of rivaroxaban application
versus dual antiplatelet therapy for prevention of device-related-thrombus in patients
undergoing left atrial appendage closure using the WATCHMAN device.